Skip to main content
Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies
April 16, 2024
[Replay] Medincell Presentation at the 23rd Annual Needham Virtual Healthcare Conference
April 11, 2024
Unitaid Awards Medincell up to $6 million Extension Grant to Fight Malaria
April 8, 2024
MedinCell to present at the 23rd Annual Needham Virtual Healthcare Conference
March 28, 2024
Pharmaceutical Industry Veteran Strategist Philippe Guy Becomes Chairman of MedinCell’s Supervisory Board
March 13, 2024
[Replay] Medincell Presentation at Evercore ISI 2024 Emerging Biotech Conference
February 28, 2024
Anh Nguyen stepped down from MedinCell Supervisory Board as Member and Chairman Due to Statutory Age Limit
February 19, 2024
MedinCell to present at the Evercore ISI 2024 Emerging Biotech Conference
February 15, 2024
MedinCell’s partner Teva provides guidance for UZEDY in 2024 and an update on olanzapine LAI (mdc-TJK)
January 31, 2024
Teva announces recruitment completion of phase 3 clinical study of mdc-TJK
January 9, 2024
